Latest News

Solar farm boosts University zero carbon bid
Thursday 24th September 2020, 3:00pm

A solar farm that will play a vital role in helping the University of Edinburgh become carbon neutral by 2040 is nearing completion.

Read More

The wider economic impacts of aquaculture
Wednesday 23rd September 2020, 12:00pm

The aquaculture sector contributed approximately £885 million to the wider Scottish economy and supported 11,700 jobs in 2018, according to new research.

Read More

Livestock surrogates successfully made fertile
Tuesday 15th September 2020, 11:00am

Research shows fertility of mammals can be restored as they produce sperm derived from donors.

Read More

Stem cell study could curb need for animal tissue
Monday 7th September 2020, 3:00pm

Insights into pig blood cell development could help limit the use of animals for research.

Read More

AbacusBio and Bayer crop collaboration
Thursday 3rd September 2020, 5:00pm

AbacusBio and Bayer collaborate, further accelerating Bayer’s Global Crop Breeding programmes.

Read More

AskBio awarded Scottish Enterprise R&D grant to fund gene therapy solutions
Thursday 3rd September 2020, 4:00pm

AskBio, a leading, clinical-stage gene therapy company dedicated to developing adeno-associated virus (AAV) gene therapies for genetic disorders, announces the award of a £1.99m R&D Grant from Scottish Enterprise.

Read More

Surrogacy method to aid welfare in poultry research
Thursday 3rd September 2020, 2:00pm

Frozen reproductive cells hatched by surrogate hens will support the formation of a chicken biobank for breeds of chicken used in research.

Read More

Brain study uncovers key to seasonal timing
Thursday 27th August 2020, 5:00pm

A binary switch in the brain regulates the biological changes needed for seasonal living, research has found.

Read More

Ingenza milestone in novel cost-effective COVID-19 vaccine technology
Thursday 20th August 2020, 4:00pm

Biotech specialist, Ingenza Ltd, has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current COVID-19 pandemic.

Read More

Carcinotech partner with Swedish biotech firm CELLINK on cancer research
Tuesday 18th August 2020, 10:30am

Life sciences start-up Carcinotech has agreed a partnership with Swedish firm CELLINK to research treatments for brain tumours and breast cancer.

Read More

Next